EDAP Received Significant Visibility for Ablatherm-HIFU at American Urological … – MarketWatch (press release)

 EDAP Received Significant Visibility for Ablatherm HIFU at American Urological ...   MarketWatch (press release)
EDAP Received Significant Visibility for Ablatherm-HIFU at American Urological
MarketWatch (press release)
This is the largest multi-center study ever presented of patients, who have undergone HIFU as a primary therapy for prostate cancer, and included patients

and more »

Bright Light Helps Soldiers Sleep – Ivanhoe

 EDAP Received Significant Visibility for Ablatherm HIFU at American Urological ...   MarketWatch (press release)
Bright Light Helps Soldiers Sleep
Ivanhoe
results are an important step to further establish the efficacy of bright light therapy as an alternative or adjunct treatment for combat-related PTSD.

and more »

cerbomed Reports Positive Intermediate Results from Epilepsy Pilot Study – Business Wire (press release)

 EDAP Received Significant Visibility for Ablatherm HIFU at American Urological ...   MarketWatch (press release)
cerbomed Reports Positive Intermediate Results from Epilepsy Pilot Study
Business Wire (press release)
This shows the enormous market potential of t-VNS ® for patients, who could profit from an alternative therapy that offers them a high clinical

and more »

John C. Lincoln hosts seminars on alternative medicine – Arizona Republic

 EDAP Received Significant Visibility for Ablatherm HIFU at American Urological ...   MarketWatch (press release)
John C. Lincoln hosts seminars on alternative medicine
Arizona Republic
and massage therapy. In 2002, a Centers for Disease Control and Prevention survey showed that more Americans are using complementary and alternative

and more »

Lancet: Targeted intraoperative radiotherapy, a viable alternative for breast … – Health Imaging & IT

6 EDAP Received Significant Visibility for Ablatherm HIFU at American Urological ...   MarketWatch (press release)
The Hindu
 EDAP Received Significant Visibility for Ablatherm HIFU at American Urological ...   MarketWatch (press release)

Molecular imaging helps predict breast cancer survival – PhysOrg.com

6 EDAP Received Significant Visibility for Ablatherm HIFU at American Urological ...   MarketWatch (press release)
Science Centric
 EDAP Received Significant Visibility for Ablatherm HIFU at American Urological ...   MarketWatch (press release)
Molecular imaging helps predict breast cancer survival
PhysOrg.com
Being able to predict the outcome of treatment could enable clinicians to discontinue futile therapies and provide the benefits of alternative therapy
Cell>Point to Present Clinical Results in Cancer Molecular Imaging with SPECT MarketWatch (press release)

all 130 news articles »

ADAMSB v. FEDERAL BUREAU OF PRISONS – Leagle.com

 EDAP Received Significant Visibility for Ablatherm HIFU at American Urological ...   MarketWatch (press release)
ADAMSB v. FEDERAL BUREAU OF PRISONS
Leagle.com
In August 2006, Plaintiff asked the Beaumont medical staff to cut her penis off for her and requested hormone therapy. Medical staff refused this request

and more »

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • MisterWong
  • Y!GG
  • Webnews
  • Digg
  • del.icio.us
  • StumbleUpon
  • Reddit
  • Ask
  • Facebook
  • YahooMyWeb
  • TwitThis
  • Furl
  • N4G
  • SEOigg